Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis

Saved in:
Bibliographic Details
Published inAmerican journal of hematology Vol. 93; no. 7; pp. E159 - E161
Main Authors Caocci, Giovanni, Mulas, Olga, Annunziata, Mario, Luciano, Luigiana, Bonifacio, Massimiliano, Orlandi, Ester Maria, Pregno, Patrizia, Galimberti, Sara, Russo Rossi, Antonella, Abruzzese, Elisabetta, Iurlo, Alessandra, Martino, Bruno, Sgherza, Nicola, Binotto, Gianni, Castagnetti, Fausto, Gozzini, Antonella, Fozza, Claudio, Bocchia, Monica, Sicuranza, Anna, Stagno, Fabio, Efficace, Fabio, Usala, Emilio, De Gregorio, Fiorenza, Scaffidi, Luigi, Elena, Chiara, Pirillo, Francesca, Baratè, Claudia, Trawinska, Malgorzata Monika, Cattaneo, Daniele, Labate, Claudia, Gugliotta, Gabriele, Molica, Matteo, Specchia, Giorgina, La Nasa, Giorgio, Foà, Robin, Breccia, Massimo
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.07.2018
Subjects
Chronic myeloid leukemia
Hematology
Myeloid leukemia
Prophylaxis
Risk factors
Toxicity
Tyrosine kinase inhibitors
Online AccessGet full text
ISSN0361-8609
1096-8652
1096-8652
DOI10.1002/ajh.25102

Cover

Author Galimberti, Sara
Labate, Claudia
Elena, Chiara
Abruzzese, Elisabetta
Efficace, Fabio
Russo Rossi, Antonella
De Gregorio, Fiorenza
Fozza, Claudio
Mulas, Olga
Cattaneo, Daniele
Iurlo, Alessandra
Trawinska, Malgorzata Monika
Usala, Emilio
Martino, Bruno
Gozzini, Antonella
Bonifacio, Massimiliano
Stagno, Fabio
Annunziata, Mario
Sicuranza, Anna
Baratè, Claudia
Pirillo, Francesca
Pregno, Patrizia
Bocchia, Monica
Castagnetti, Fausto
Molica, Matteo
Binotto, Gianni
Luciano, Luigiana
Orlandi, Ester Maria
Scaffidi, Luigi
Caocci, Giovanni
Foà, Robin
Gugliotta, Gabriele
Sgherza, Nicola
Specchia, Giorgina
La Nasa, Giorgio
Breccia, Massimo
Author_xml – sequence: 1
  givenname: Giovanni
  orcidid: 0000-0002-6585-5187
  surname: Caocci
  fullname: Caocci, Giovanni
  email: giovanni.caocci@unica.it
  organization: University of Cagliari
– sequence: 2
  givenname: Olga
  surname: Mulas
  fullname: Mulas, Olga
  organization: Hematology and Transplant Center
– sequence: 3
  givenname: Mario
  surname: Annunziata
  fullname: Annunziata, Mario
  organization: Hematology Unit, Cardarelli Hospital
– sequence: 4
  givenname: Luigiana
  surname: Luciano
  fullname: Luciano, Luigiana
  organization: Hematology Unit “Federico II” University of Naples
– sequence: 5
  givenname: Massimiliano
  surname: Bonifacio
  fullname: Bonifacio, Massimiliano
  organization: Section of Hematology, University of Verona
– sequence: 6
  givenname: Ester Maria
  surname: Orlandi
  fullname: Orlandi, Ester Maria
  organization: Hematology Unit, “Fondazione IRCCS Policlinico S. Matteo” University Hospital
– sequence: 7
  givenname: Patrizia
  surname: Pregno
  fullname: Pregno, Patrizia
  organization: Hematology Unit, Azienda Ospedaliero‐Universitaria Città della Salute e della Scienza
– sequence: 8
  givenname: Sara
  orcidid: 0000-0002-4620-0038
  surname: Galimberti
  fullname: Galimberti, Sara
  organization: Section of Hematology, University of Pisa
– sequence: 9
  givenname: Antonella
  surname: Russo Rossi
  fullname: Russo Rossi, Antonella
  organization: Hematology and Transplants Unit, University of Bari
– sequence: 10
  givenname: Elisabetta
  surname: Abruzzese
  fullname: Abruzzese, Elisabetta
  organization: Hematology Unit, Sant'Eugenio Hospital Tor Vergata University
– sequence: 11
  givenname: Alessandra
  orcidid: 0000-0002-4401-0812
  surname: Iurlo
  fullname: Iurlo, Alessandra
  organization: Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
– sequence: 12
  givenname: Bruno
  surname: Martino
  fullname: Martino, Bruno
  organization: Hematology Unit, Azienda Ospedaliera “Bianchi‐Melacrino‐Morelli”
– sequence: 13
  givenname: Nicola
  surname: Sgherza
  fullname: Sgherza, Nicola
  organization: Hematology and Transplant Center
– sequence: 14
  givenname: Gianni
  surname: Binotto
  fullname: Binotto, Gianni
  organization: Hematology Unit, University of Padova
– sequence: 15
  givenname: Fausto
  surname: Castagnetti
  fullname: Castagnetti, Fausto
  organization: S. Orsola‐Malpighi Hospital, University of Bologna
– sequence: 16
  givenname: Antonella
  surname: Gozzini
  fullname: Gozzini, Antonella
  organization: Hematology Unit, AOU Careggi, University of Florence
– sequence: 17
  givenname: Claudio
  orcidid: 0000-0001-7253-5432
  surname: Fozza
  fullname: Fozza, Claudio
  organization: University of Sassari
– sequence: 18
  givenname: Monica
  orcidid: 0000-0003-3538-3913
  surname: Bocchia
  fullname: Bocchia, Monica
  organization: Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena
– sequence: 19
  givenname: Anna
  surname: Sicuranza
  fullname: Sicuranza, Anna
  organization: Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena
– sequence: 20
  givenname: Fabio
  surname: Stagno
  fullname: Stagno, Fabio
  organization: Hematology Unit, Ferrarotto Hospital
– sequence: 21
  givenname: Fabio
  orcidid: 0000-0002-5065-5166
  surname: Efficace
  fullname: Efficace, Fabio
  organization: Data Center and Health Outcomes Research Unit
– sequence: 22
  givenname: Emilio
  surname: Usala
  fullname: Usala, Emilio
  organization: Hematology and Transplant Center
– sequence: 23
  givenname: Fiorenza
  surname: De Gregorio
  fullname: De Gregorio, Fiorenza
  organization: Hematology Unit “Federico II” University of Naples
– sequence: 24
  givenname: Luigi
  surname: Scaffidi
  fullname: Scaffidi, Luigi
  organization: Section of Hematology, University of Verona
– sequence: 25
  givenname: Chiara
  surname: Elena
  fullname: Elena, Chiara
  organization: Hematology Unit, “Fondazione IRCCS Policlinico S. Matteo” University Hospital
– sequence: 26
  givenname: Francesca
  surname: Pirillo
  fullname: Pirillo, Francesca
  organization: Hematology Unit, Azienda Ospedaliero‐Universitaria Città della Salute e della Scienza
– sequence: 27
  givenname: Claudia
  surname: Baratè
  fullname: Baratè, Claudia
  organization: Section of Hematology, University of Pisa
– sequence: 28
  givenname: Malgorzata Monika
  surname: Trawinska
  fullname: Trawinska, Malgorzata Monika
  organization: Hematology Unit, Sant'Eugenio Hospital Tor Vergata University
– sequence: 29
  givenname: Daniele
  surname: Cattaneo
  fullname: Cattaneo, Daniele
  organization: Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
– sequence: 30
  givenname: Claudia
  surname: Labate
  fullname: Labate, Claudia
  organization: Hematology Unit, Azienda Ospedaliera “Bianchi‐Melacrino‐Morelli”
– sequence: 31
  givenname: Gabriele
  surname: Gugliotta
  fullname: Gugliotta, Gabriele
  organization: S. Orsola‐Malpighi Hospital, University of Bologna
– sequence: 32
  givenname: Matteo
  orcidid: 0000-0001-6391-4406
  surname: Molica
  fullname: Molica, Matteo
  organization: Policlinico Umberto I, Sapienza University
– sequence: 33
  givenname: Giorgina
  surname: Specchia
  fullname: Specchia, Giorgina
  organization: Hematology and Transplants Unit, University of Bari
– sequence: 34
  givenname: Giorgio
  surname: La Nasa
  fullname: La Nasa, Giorgio
  organization: University of Cagliari
– sequence: 35
  givenname: Robin
  surname: Foà
  fullname: Foà, Robin
  organization: Policlinico Umberto I, Sapienza University
– sequence: 36
  givenname: Massimo
  orcidid: 0000-0003-1163-6162
  surname: Breccia
  fullname: Breccia, Massimo
  organization: Policlinico Umberto I, Sapienza University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29633312$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9u1DAQhy1URLeFAy-ALHGBw7aO859btaK0qBIXOEeOPSGz69jBdmhz4xH6crwAT4K32V4qONnSfL9vrPGckCNjDRDyOmFnCWP8XGz7M54njD8jq4TVxboqcn5EViwtknhn9TE58X7LWJJkFXtBjnldpGma8BX5vRFOof0pvJy0cDTYO5QYZoqGjiIgmODpLYaeyt5Zg5IOM2iLimqYdjCgoMGBCKAWyoO0Rv35df8dDLgosIaG2VmPBugOjfAQ1T22GKzz-y6hBxoNOmY0dkBHJ2RACR_otYrdsUO5aGxHHfod7WJ9nxVGLWGrYV8cnR37WYs79C_J805oD68O5yn5dvnx6-ZqffPl0_Xm4mYt06ria1mXNVNVnkGWqK7jqmU8VkBBIWtRy1pBrsqSVVWueN7KStS8UF3eZoUqoczTU_Ju8cbePybwoRnQS9BaGLCTbzjjacnrLOcRffsE3drJmfi6SBVFmhesrCL15kBN7QCqGR0Ows3N44dF4HwBZJypd9A18bce5hOcQN0krNmvRBNXonlYiZh4_yTxKP0Xe7Dfoob5_2Bz8flqSfwF15PM_w
CitedBy_id crossref_primary_10_5124_jkma_2023_66_4_224
crossref_primary_10_1016_j_htct_2020_04_009
crossref_primary_10_1038_s41598_021_94127_2
crossref_primary_10_1002_hon_2765
crossref_primary_10_1007_s11864_023_01149_1
crossref_primary_10_1002_hon_2606
crossref_primary_10_3389_fonc_2022_835563
crossref_primary_10_1016_j_ijcard_2019_04_051
crossref_primary_10_1186_s12872_022_02504_0
crossref_primary_10_3390_cancers13071643
crossref_primary_10_1007_s00277_020_04102_6
crossref_primary_10_3390_jcm9041180
crossref_primary_10_1007_s00277_020_04392_w
crossref_primary_10_1007_s00277_023_05556_0
crossref_primary_10_1002_ehf2_15165
crossref_primary_10_1159_000493636
crossref_primary_10_1038_s41598_023_39057_x
crossref_primary_10_1080_00015385_2021_1888017
crossref_primary_10_1002_advs_202104850
crossref_primary_10_1007_s00277_019_03705_y
crossref_primary_10_1016_j_phrs_2020_104866
crossref_primary_10_3390_ijms232012271
crossref_primary_10_3390_jcm9103269
crossref_primary_10_1016_j_ijcard_2019_10_036
crossref_primary_10_1002_ehf2_13897
crossref_primary_10_1007_s11899_019_00550_8
Cites_doi 10.2147/VHRM.S108874
10.1007/s00277-014-2231-9
10.3324/haematol.2016.144949
10.1016/j.clml.2017.06.011
10.1007/s00277-017-3012-z
10.7326/M15-2306
10.1002/hon.2274
ContentType Journal Article
Copyright 2018 Wiley Periodicals, Inc.
Copyright_xml – notice: 2018 Wiley Periodicals, Inc.
DBID AAYXX
CITATION
NPM
K9.
7X8
DOI 10.1002/ajh.25102
DatabaseName CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1096-8652
EndPage E161
ExternalDocumentID 29633312
10_1002_ajh_25102
AJH25102
Genre letter
Letter
Correspondence
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23M
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDPE
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AI.
AIACR
AIAGR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EGARE
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IH2
IX1
J0M
J5H
JPC
KBYEO
KD1
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RX1
RYL
SAMSI
SUPJJ
TEORI
TR2
UB1
V2E
V8K
VH1
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAHHS
AAYXX
ACCFJ
ADZOD
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
24P
AEUQT
AFPWT
NPM
RWI
WRC
WUP
WWO
K9.
7X8
ID FETCH-LOGICAL-c3882-c9790d854e41dff2db02c38ede6c9a9c9de5d770885d25bc8a926df5b46d7e753
IEDL.DBID DR2
ISSN 0361-8609
1096-8652
IngestDate Fri Jul 11 14:12:05 EDT 2025
Fri Jul 25 12:10:40 EDT 2025
Wed Feb 19 02:36:36 EST 2025
Thu Apr 24 23:10:16 EDT 2025
Tue Jul 01 02:28:02 EDT 2025
Wed Aug 20 07:26:38 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3882-c9790d854e41dff2db02c38ede6c9a9c9de5d770885d25bc8a926df5b46d7e753
Notes Funding information
None
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Correspondence-1
ORCID 0000-0003-1163-6162
0000-0002-6585-5187
0000-0001-7253-5432
0000-0002-5065-5166
0000-0002-4620-0038
0000-0003-3538-3913
0000-0002-4401-0812
0000-0001-6391-4406
OpenAccessLink http://hdl.handle.net/11365/1050161
PMID 29633312
PQID 2066356078
PQPubID 866345
PageCount 3
ParticipantIDs proquest_miscellaneous_2023729452
proquest_journals_2066356078
pubmed_primary_29633312
crossref_citationtrail_10_1002_ajh_25102
crossref_primary_10_1002_ajh_25102
wiley_primary_10_1002_ajh_25102_AJH25102
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2018
2018-07-00
20180701
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: July 2018
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle American journal of hematology
PublicationTitleAlternate Am J Hematol
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2016; 101
2016; 165
2017; 96
2017; 17
2015; 94
2017; 13
2017; 35
e_1_2_2_4_1
e_1_2_2_5_1
e_1_2_2_6_1
e_1_2_2_7_1
e_1_2_2_2_1
e_1_2_2_3_1
e_1_2_2_8_1
References_xml – volume: 13
  start-page: 293
  year: 2017
  end-page: 303
  article-title: Cardiovascular toxicities of BCR‐ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
  publication-title: VHRM.
– volume: 94
  start-page: 393
  issue: 3
  year: 2015
  end-page: 397
  article-title: Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment
  publication-title: Ann Hematol.
– volume: 165
  start-page: 161
  issue: 3
  year: 2016
  end-page: 166
  article-title: Cardiovascular events associated with use of tyrosine kinase inhibitors in chronic myeloid leukemia: a population‐based cohort study
  publication-title: Ann Intern Med.
– volume: 35
  start-page: 232
  issue: 2
  year: 2017
  end-page: 236
  article-title: Impact of exclusion criteria for the DASISION and ENESTnd trials in the front‐line treatment of a 'real‐life' patient population with chronic myeloid leukaemia
  publication-title: Hematol Oncol.
– volume: 96
  start-page: 1303
  issue: 8
  year: 2017
  end-page: 1313
  article-title: Evaluation of cardiovascular ischemic event rates in dasatinib‐treated patients using standardized incidence ratios
  publication-title: Ann Hematol.
– volume: 17
  start-page: 676
  issue: 10
  year: 2017
  end-page: 683
  article-title: Elevated cardiovascular disease risk in patients with chronic myelogenous leukemia seen in community‐based oncology practices in the United States
  publication-title: Clin Lymphoma Myeloma Leuk.
– volume: 101
  start-page: 1200
  issue: 10
  year: 2016
  end-page: 1207
  article-title: Nilotinib 300 mg twice daily: an academic single‐arm study of newly diagnosed chronic phase chronic myeloid leukemia patients
  publication-title: Haematologica.
– ident: e_1_2_2_4_1
  doi: 10.2147/VHRM.S108874
– ident: e_1_2_2_5_1
  doi: 10.1007/s00277-014-2231-9
– ident: e_1_2_2_6_1
  doi: 10.3324/haematol.2016.144949
– ident: e_1_2_2_2_1
  doi: 10.1016/j.clml.2017.06.011
– ident: e_1_2_2_8_1
  doi: 10.1007/s00277-017-3012-z
– ident: e_1_2_2_3_1
  doi: 10.7326/M15-2306
– ident: e_1_2_2_7_1
  doi: 10.1002/hon.2274
SSID ssj0011480
Score 2.358046
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage E159
SubjectTerms Chronic myeloid leukemia
Hematology
Myeloid leukemia
Prophylaxis
Risk factors
Toxicity
Tyrosine kinase inhibitors
Title Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fajh.25102
https://www.ncbi.nlm.nih.gov/pubmed/29633312
https://www.proquest.com/docview/2066356078
https://www.proquest.com/docview/2023729452
Volume 93
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaqHhAXflp-Fko1IIR6yXbjjZMYTqtCtRSVA6JSD0iRHds0bDZBJCt1OfEIvBwvwJMwtpOg5UdC3CLN2E6cGfsbe_yZkMfoX5FmGKYqGqdBJIUOeMpMkJiQGsFjIxJ73vn0dTw_i07O2fkWedafhfH8EMOCm_UMN15bBxeyOfxJGio-XIxxcnZEkuE0trz5z98M1FEW5k_8PmUYpPGE96xCE3o4lNyci34DmJt41U04x9fJu_5VfZ7JYrxq5Tj__AuL439-yw1yrQOiMPOWc5Ns6WqH7M4qDMKXa3gCLjXUrbnvkCun3Q78Lvl2tJHACm19iZJ2DUUFHUdrA3ZxF3JPuwvLtS7rQkGpVwu9LAS43HatvFZjA3L1_cvX947_2poJtGvsLmwNFkWFkyxWfVHIwl4LZFtBxApYQ4llysJo6M95PQV_6Nh0q5BQG7CJ89BdKQSiUr5wXWorxJ5FGyvFZdHcImfHL94ezYPuaoggn9qYIOcJn6iURToKlTFUyQlFiVY6zrngOVeaqSTBIZQpymSeCk5jZZiMYpVoDNFuk-2qrvRdAqiRpCriymCwy4UUiKmMTHImDUI7KUfkoDeSLO940-31HWXmGZ9phn8vc39vRB4Nqh89WciflPZ6S8u68aLJqEN-MeK1EXk4iNHT7faNqHS9sjrU7rFGDKu44y10aIXiODqdhig5cHb29-az2cncPdz7d9X75CrixNRnKe-R7fbTSj9ALNbKfXS6l6_2nev9AOsaOFQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaqVgIuFFoo2xYYEEK9ZJv15s-Iy6qiWkq3B9RKvaDIjm0aNpsgNit1OfEIvBwvwJMwtpOg5UdC3CLNOM7PjP3NePyZkGfoX4EKMUyVNEq8QHDlsSTUXqwHVHMWaR6b_c6Ts2h8EZxchpdr5GW7F8bxQ3QJN-MZdrw2Dm4S0oc_WUP5h6s-zs6GSXLDrs8ZSPS2I48yQN93K5UDL4l81vIK-fSwa7o6G_0GMVcRq51yjjfJu_ZhXaXJtL-oRT_7_AuP4_--zR1yu8GiMHLGc5esqXKLbI9KjMNnS3gOtjrUpt23yI1Jswi_Tb4drdSwQl1do6ReQl5CQ9M6B5Pfhcwx78JsqYoql1CoxVTNcg62vF1JpzU3Mbn8_uXre0uBbSwF6iV-L-wNpnmJ8yze-ioXuTkZyPSCoBXwDgW2KXKtoN3q9QLcvmPdJCKh0mBq56E5VQh4KV3jqlBGiJ8Wzazg1_n8Hrk4fnV-NPaa0yG8bGjCgozFzJdJGKhgILWmUvgUJUqqKGOcZUyqUMYxjqKhpKHIEs5oJHUogkjGCqO0-2S9rEr1gABqxIkMmNQY7zIuOMIqLeIsFBrRnRA9ctBaSZo11OnmBI8idaTPNMW_l9q_1yNPO9WPji_kT0r7ramlzZAxT6kFfxFCth550onR2c0KDi9VtTA61Cyzoq33yI4z0a4XikPpcDhAyYE1tL93n45OxvZi999VH5Ob4_PJaXr6-uzNHrmFsDFxRcv7ZL3-tFAPEZrV4pH1wB_dVTt5
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLamIU3c8LPxUxhwQAjtJl3rxkkMV9WgKoNNCDFpF0iRHdssNE0mmkorVzwCL8cL8CQc20lQ-ZEQd5XOsd0k5_h8xz7-TMhj9K9QM0xTFY2SIJRCBzxhJojNkBrBIyNie9756DianoSHp-x0gzxrz8J4fohuwc16hpuvrYOfK7P_kzRUfDzrY3C2RJKXwgjDpEVEbzvuKIvzB36jchgk0YC3tEIDut81XQ9GvyHMdcDqIs7kKnnf_ldfaDLrL2vZzz7_QuP4nw9zjVxpkCiMvelcJxu63CY74xKz8PkKnoCrDXWL7ttk66jZgt8h3w7WKlihri5QUq8gL6EhaV2AXd2FzPPuwnyliypXUOjlTM9zAa64XSuvtbAZufr-5esHR4Bt7QTqFb4uHA1meYlRFrs-y2Vu7wWyoyBkBeyhwDZFbjS0B72egj91bJplSKgM2Mp5aO4UAlEq37gqtBXim0UjK8RFvrhBTiYv3h1Mg-ZuiCAb2aQg4zEfqISFOhwqY6iSA4oSrXSUccEzrjRTcYxzKFOUySwRnEbKMBlGKtaYo90km2VV6tsEUCNOVMiVwWyXCykQVBkZZ0waxHZS9sheayRp1hCn2_s7itRTPtMUv17qvl6PPOpUzz1byJ-UdltLS5sJY5FSB_0iBGw98rATo6vb_RtR6mppdajdZA0ZdnHLW2g3CsWJdDQaomTP2dnfh0_Hh1P3486_qz4gW2-eT9LXL49f3SWXETMmvmJ5l2zWn5b6HuKyWt53_vcDE4o6KA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cardiovascular+toxicity+in+patients+with+chronic+myeloid+leukemia+treated+with+second%E2%80%90generation+tyrosine+kinase+inhibitors+in+the+real%E2%80%90life+practice%3A+Identification+of+risk+factors+and+the+role+of+prophylaxis&rft.jtitle=American+journal+of+hematology&rft.au=Caocci%2C+Giovanni&rft.au=Mulas%2C+Olga&rft.au=Annunziata%2C+Mario&rft.au=Luciano%2C+Luigiana&rft.date=2018-07-01&rft.issn=0361-8609&rft.eissn=1096-8652&rft.volume=93&rft.issue=7&rft_id=info:doi/10.1002%2Fajh.25102&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_ajh_25102
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0361-8609&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0361-8609&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0361-8609&client=summon